stocksINVICTA
INVICTA

Invicta Diagnostic Ltd.

70.00+0.5 (+0.72%)
24 Aug, 12:00 AM

Annual Reports and Financial Documents

Invicta Diagnostic Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual Reports
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Invicta Diagnostic Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Outcome of Board Meeting29 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on July 29, 2026. Board at its meeting held today1. The Board took on record and accepted the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director (Finance) and Director of the Company2. The Board accepted the resignation of Ms. Konica Rohit Srivastava from the office of Manager of the Company3. The Board appointed Mr. Sanket Vinod Jain (DIN: 08299039) as Managing Director of the Company 4. The Board approved sale/disposal of the Company's entire stake representing 50% partnership interest in MSCRIBEIT INFOTECH LLP, an associate LLP of the Company5. The Board approved Reconstitution of Stakeholders Relationship Committee
  2. Trading Window23 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  3. Change in Director(s)23 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange regarding Change in Director(s) of the company.
  4. Change in Management20 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange about change in Management of Porteus Pathogenius LLP, a subsidiary of Porteus Medical LLP, which is a subsidiary of Invicta Diagnostic Limited
  5. Certificate under SEBI (Depositories and Participants) Regulations, 201810 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange about Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2026
  6. Press Release1 Jul 2026
    Invicta Diagnostic Limited has informed the Exchange regarding a press release dated July 01, 2026, titled Invicta Diagnostic Limited Starts Commercial Operations at Pune Centre; Total Network Reaches 10 Diagnostic Centres.
  7. Commencement of commercial production/operations30 Jun 2026
    Invicta Diagnostic Limited has informed the Exchange that Company's Subsidiary LLP i.e. Porteus Medical LLP has established its diagnostic services centre at Pune Centre and it has started commercial operations on 30 June, 2026
  8. Acquisition12 Jun 2026
    Invicta Diagnostic Limited has informed the Exchange that Porteus Medical LLP a subsidiary LLP of the Company, has incorporated a Limited Liability Partnership namely Porteus Pathogenius LLP and Consequent to the above incorporation, Porteus Pathogenius LLP has become a Step-Down Subsidiary of the Company. Further the Initial LLP agreement of Porteus Pathogenius LLP dated 12 June, 2026 has been executed today
  9. Acquisition1 Jun 2026
    Invicta Diagnostic Limited has informed the Exchange about Incorporation of Step-Down Subsidiary LLP
  10. Statement of deviation(s) or variation(s) under Reg. 3229 May 2026
    Invicta Diagnostic Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  11. Updates25 May 2026
    Invicta Diagnostic Limited has informed the Exchange regarding 'machine Readable Copy of Financial Results (Standalone and Consolidated) of the Company for the Half Year and Financial Year ended March 31, 2026.'.
  12. Analysts/Institutional Investor Meet/Con. Call Updates25 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Transcript of Earnings Conference Call with Investor and Analyst held on Saturday, 23rd May 2026.
  13. Analysts/Institutional Investor Meet/Con. Call Updates23 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Link of audio recording of the Investor and Analyst Earnings Conference Call held on Saturday, 23rd May, 2026 at 12:00 P.M. (IST) to discuss the operational and financial in relation to the financial results of the Company for the half year ended 31st March, 2026.
  14. Analysts/Institutional Investor Meet/Con. Call Updates22 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Presentation
  15. Product launch22 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Launch of services to clients from United States of America
  16. Copy of Newspaper Publication19 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results for the Half Year and Financial Year ended March 31, 2026
  17. Analysts/Institutional Investor Meet/Con. Call Updates19 May 2026
    Invicta Diagnostic Limited has informed the Exchange about Schedule of meet
  18. Press Release19 May 2026
    Invicta Diagnostic Limited has informed the Exchange regarding a press release dated May 19, 2026, titled Invicta Diagnostic Limited Reports FY26 Total Income of ₹33.04 Cr with EBITDA Margins Above 30%.
  19. Disclosure under SEBI Takeover Regulations18 May 2026
    Rohit Prakash Srivastava has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  20. Outcome of Board Meeting18 May 2026
    Invicta Diagnostic Limited has submitted to the Exchange, the standalone and consolidated financial results for the period ended March 31, 2026.

Frequently Asked Questions

Where can I download the annual report of Invicta Diagnostic Ltd.?
Annual reports of Invicta Diagnostic Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Invicta Diagnostic Ltd.?
Quarterly earnings results and presentations of Invicta Diagnostic Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Invicta Diagnostic Ltd. publish earnings call transcripts?
Earnings call transcripts of Invicta Diagnostic Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Invicta Diagnostic Ltd.?
Investor presentations and annual day presentations of Invicta Diagnostic Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Invicta Diagnostic Ltd.?
Corporate announcements and regulatory filings of Invicta Diagnostic Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Invicta Diagnostic Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Invicta Diagnostic Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Invicta Diagnostic Ltd.?
The ISIN (International Securities Identification Number) of Invicta Diagnostic Ltd. is INE0XJ501010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Invicta Diagnostic Ltd. listed?
Invicta Diagnostic Ltd. is listed on NSE and BSE. The NSE symbol is INVICTA and the BSE code is -.
Where can I find the shareholding pattern of Invicta Diagnostic Ltd.?
The quarterly shareholding pattern of Invicta Diagnostic Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Invicta Diagnostic Ltd. on Sharpely?
Share price data for Invicta Diagnostic Ltd. is updated as of 24 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.